These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5134227)

  • 1. Amine metabolism in the human brain: further evaluation of the probenecid test.
    Korf J; Van Praag HM
    Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Chase RN; Schnur JA; Brody JA; Gordon EK
    Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 6. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
    Gottfires CG; Roos BE
    Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 8. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.
    Bowers MB
    Neuropharmacology; 1972 Jan; 11(1):101-11. PubMed ID: 5060511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.
    McKean CM
    Brain Res; 1972 Dec; 47(2):469-76. PubMed ID: 4642573
    [No Abstract]   [Full Text] [Related]  

  • 12. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 14. REM sleep and central monoamine oxidase inhibition.
    Kupfer DJ; Bowers MB
    Psychopharmacologia; 1972; 27(3):183-90. PubMed ID: 4345178
    [No Abstract]   [Full Text] [Related]  

  • 15. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man.
    van Praag HM; Flentge F; Korf J; Dols LC; Schut T
    Psychopharmacologia; 1973; 33(2):141-51. PubMed ID: 4775879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid and brain of different rabbit breeds after treatment with probenecid.
    Andersson H; Roos BE
    J Pharm Pharmacol; 1972 Feb; 24(2):165-6. PubMed ID: 4401976
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.